Maryland State Retirement & Pension System’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-23,138
Closed -$152K 1574
2023
Q2
$152K Hold
23,138
﹤0.01% 1551
2023
Q1
$157K Hold
23,138
﹤0.01% 1499
2022
Q4
$171K Buy
+23,138
New +$225K 0.01% 1474
2022
Q3
Sell
-22,535
Closed -$246K 1336
2022
Q2
$246K Hold
22,535
0.01% 1365
2022
Q1
$255K Buy
22,535
+472
+2% +$6.21K 0.01% 1398
2021
Q4
$346K Buy
22,063
+246
+1% +$4.29K 0.01% 1302
2021
Q3
$382K Buy
+21,817
New +$382K 0.01% 1247

Other funds holding VNDA

Maryland State Retirement & Pension System's VNDA Position: Q3 2023 in Review

Maryland State Retirement & Pension System sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 23,138 shares — an estimated $152K sold.

Maryland State Retirement & Pension System first reported a position in VNDA in Q3 2021 and held it in 7 quarters. The position peaked at $382K in Q3 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Maryland State Retirement & Pension System reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 23,138 Vanda Pharmaceuticals shares in Q3 2023, an estimated $152K.
  • Maryland State Retirement & Pension System first reported a position in Vanda Pharmaceuticals in Q3 2021 and held it in 7 quarters.
  • Maryland State Retirement & Pension System's Vanda Pharmaceuticals position peaked at $382K in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2023, filed 24 Oct 2023.